6 Views
The Lorazepam Prices commenced on a higher note in the North American region during the H1 of Q3, with healthy demand witnessed from the downstream sector, then followed the declining trajectory from the mid-half of q3 till the end of September, which was supported by the sufficient supplies with the domestic merchants. Furthermore, halted trading momentum from the exporting countries leading to accumulated cargoes at the ports, assisted the market sentiments of Lorazepam in the USA. Overall, the pricing trends displayed towards the end of q3 were assessed at USD 850/MT CFR Los Angeles in the United States.
For more information
E-Mail:- [email protected]
websites:- https://www.chemanalyst.com/Pricing-data/lorazepam-1382
Contact No:- +13322586602
